(Q60242775)

3 July 2019

title

Progression in disability and regional grey matter atrophy in relapsing–remitting multiple sclerosis (English)

1 reference

3 July 2019

Till Sprenger

10

0 references

Stefan J Borgwardt

Stefan J Borgwardt

17

0 references

Renata Smieskova

6

Renata Smieskova

0 references

Ludwig Kappos

8

Ludwig Kappos

1 reference

3 July 2019

14

Frederik Barkhof

1 reference

3 July 2019

12

Thomas E Nichols

1 reference

3 July 2019

Nicole Mueller-Lenke

7

Nicole Mueller-Lenke

1 reference

3 July 2019

Stefan Traud

5

Stefan Traud

1 reference

3 July 2019

Ernst-Wilhelm Radue

16

Ernst-Wilhelm Radue

1 reference

3 July 2019

Yvonne Naegelin

2

Yvonne Naegelin

1 reference

3 July 2019

Iris-Katharina Penner

11

Iris-Katharina Penner

1 reference

3 July 2019

Achim Gass

9

Achim Gass

1 reference

3 July 2019

Pascal Kuster

4

Pascal Kuster

1 reference

3 July 2019

Lukas Filli

3

Lukas Filli

1 reference

3 July 2019

Louis Hofstetter

1

Louis Hofstetter

1 reference

3 July 2019

Hugo Vrenken

13

Hugo Vrenken

1 reference

3 July 2019

Chris Polman

15

Chris Polman

1 reference

3 July 2019

Kerstin Bendfeldt

18

Kerstin Bendfeldt

1 reference

3 July 2019

publication date

26 June 2013

1 reference

3 July 2019

Multiple Sclerosis Journal

published in

1 reference

3 July 2019

volume

20

1 reference

3 July 2019

issue

2

1 reference

3 July 2019

page(s)

202-213

1 reference

3 July 2019

Voxel-based morphometry–the methods

cites work

1 reference

12 December 2020

Regional brain atrophy is associated with physical disability in multiple sclerosis: semiquantitative magnetic resonance imaging and relationship to clinical findings.

1 reference

12 December 2020

A voxel-based morphometric study of ageing in 465 normal adult human brains

1 reference

12 December 2020

Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

1 reference

12 December 2020

The clinico-radiological paradox in multiple sclerosis revisited

1 reference

12 December 2020

Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance

1 reference

12 December 2020

Eight-year follow-up study of brain atrophy in patients with MS.

1 reference

12 December 2020

Evidence of early cortical atrophy in MS: relevance to white matter changes and disability

1 reference

12 December 2020

Focal thinning of the cerebral cortex in multiple sclerosis

1 reference

12 December 2020

Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Relating neocortical pathology to disability progression in multiple sclerosis using MRI

1 reference

12 December 2020

Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype.

1 reference

12 December 2020

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

12 December 2020

Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS.

1 reference

12 December 2020

Localization of grey matter atrophy in early RRMS : A longitudinal study

1 reference

12 December 2020

Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability

1 reference

12 December 2020

Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis

1 reference

12 December 2020

Regional brain atrophy development is related to specific aspects of clinical dysfunction in multiple sclerosis

1 reference

12 December 2020

Gray matter atrophy in multiple sclerosis: a longitudinal study

1 reference

12 December 2020

Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis — A longitudinal voxel-based morphometry study

1 reference

12 December 2020

Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.

1 reference

12 December 2020

Imaging outcomes for neuroprotection and repair in multiple sclerosis trials

1 reference

12 December 2020

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

1 reference

12 December 2020

A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.

1 reference

12 December 2020

Relationship of cortical atrophy to fatigue in patients with multiple sclerosis

1 reference

12 December 2020

The multiple sclerosis functional composite: a clinically meaningful measure of disability

1 reference

12 December 2020

Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing—remitting multiple sclerosis

1 reference

12 December 2020

Cervical cord and brain grey matter atrophy independently associate with long-term MS disability

1 reference

12 December 2020

Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis.

1 reference

12 December 2020

Voxelwise Assessment of the Regional Distribution of Damage in the Brains of Patients with Multiple Sclerosis and Fatigue

1 reference

12 December 2020

The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis

1 reference

12 December 2020

Longitudinal gray matter changes in multiple sclerosis--differential scanner and overall disease-related effects.

1 reference

12 December 2020

Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis

1 reference

12 December 2020

Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects

1 reference

12 December 2020

Identifiers

DOI

10.1177/1352458513493034

1 reference

3 July 2019

PMC publication ID

6534500

1 reference

3 July 2019

PubMed publication ID

23804554

1 reference

3 July 2019